We are live on ! Find out more
VMD icon

Viemed Healthcare

88 hedge funds and large institutions have $218M invested in Viemed Healthcare in 2023 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 37 increasing their positions, 17 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,700% more call options, than puts

Call options by funds: $280K | Put options by funds: $10K

118% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 17

78% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 9

44% more capital invested

Capital invested by funds: $151M → $218M (+$66.4M)

9% more funds holding

Funds holding: 8188 (+7)

4.79% more ownership

Funds ownership: 53.8%58.6% (+4.8%)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

Holders
88
Holders Change
+7
Holders Change %
+8.64%
% of All Funds
1.4%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
16
Increased
37
Reduced
17
Closed
9
Calls
$280K
Puts
$10K
Net Calls
+$270K
Net Calls Change
-$240K
Name Holding Trade Value Shares
Change
Change in
Stake
JF
51
Jump Financial
Illinois
$247K +$223K +25,542 New
OSAM
52
O'Shaughnessy Asset Management
Connecticut
$245K +$42K +4,812 +23%
LP
53
LMR Partners
United Kingdom
$233K +$90.6K +10,395 +76%
BA
54
Bard Associates
Illinois
$232K +$8.72K +1,000 +4%
BA
55
BCM Advisors
Louisiana
$229K +$39.2K +4,500 +27%
William Blair & Company
56
William Blair & Company
Illinois
$222K
SRCM
57
Sage Rock Capital Management
New York
$200K -$486K -55,800 -73%
AA
58
Ancora Advisors
Ohio
$192K -$388K -44,490 -69%
Geode Capital Management
59
Geode Capital Management
Massachusetts
$188K
Marshall Wace
60
Marshall Wace
United Kingdom
$179K +$162K +18,534 New
6CM
61
683 Capital Management
New York
$174K -$65.4K -7,507 -29%
GC
62
Globeflex Capital
California
$165K +$149K +17,064 New
CCIA
63
Campbell & Co Investment Adviser
Maryland
$158K +$142K +16,316 New
Man Group
64
Man Group
United Kingdom
$158K -$149K -17,127 Closed
YIH
65
Y-Intercept (HK)
Hong Kong
$154K +$139K +15,929 New
Barclays
66
Barclays
United Kingdom
$149K +$4.32K +495 +3%
RWM
67
Ritholtz Wealth Management
New York
$145K +$24.3K +2,786 +23%
SIC
68
Salem Investment Counselors
North Carolina
$145K +$95.9K +11,000 +273%
Victory Capital Management
69
Victory Capital Management
Texas
$143K
Balyasny Asset Management
70
Balyasny Asset Management
Illinois
$134K -$64.4K -7,382 -35%
BFM
71
Boothbay Fund Management
New York
$130K +$11K +1,259 +10%
SSA
72
Schonfeld Strategic Advisors
New York
$128K +$116K +13,251 New
JFG
73
Jefferies Financial Group
New York
$125K +$113K +12,910 New
National Bank of Canada
74
National Bank of Canada
Quebec, Canada
$113K +$65.4K +7,504 +181%
AIP
75
Ahrens Investment Partners
Louisiana
$75.9K +$68.5K +7,855 New

VMD Hedge Fund Activity: Q1 2023 in Review

88 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Viemed Healthcare (VMD) for Q1 2023, worth a combined $218M — up 44% from $151M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new VMD positions and 9 closed out — a net gain of 7 holders — while 37 added to existing stakes and 17 trimmed.

The largest buyer was Triasima Portfolio Management, opening a new position worth an estimated $5.17M. The largest seller was EAM Global Investors, cutting an estimated $2.49M.

  • 88 institutional investors held Viemed Healthcare (VMD) as of Q1 2023, up from 81 in Q4 2022.
  • Funds reported $218M of Viemed Healthcare stock for Q1 2023, up 44% quarter-over-quarter.
  • 16 funds opened new Viemed Healthcare positions in Q1 2023 and 9 closed out, a net change of +7 holders.
  • The largest Viemed Healthcare buyer in Q1 2023 was Triasima Portfolio Management, an estimated $5.17M added.
  • The largest Viemed Healthcare seller in Q1 2023 was EAM Global Investors, an estimated $2.49M sold.

Based on aggregated 13F filings for Q1 2023.